Benjamin A Steinberg
Affiliation: Duke University Medical Center
- Structure-function relationships of factor Xa inhibitors: implications for the practicing clinicianBenjamin A Steinberg
Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA
J Thromb Thrombolysis 37:234-41. 2014..The current review describes the development and pharmacokinetic properties of these agents, in the context of their clinical utility and pitfalls. ..
- Cardiac conduction system disease after transcatheter aortic valve replacementBenjamin A Steinberg
Division of Cardiology, Department of Medicine, DukeUniversity Hospital, Durham, NC 27705, USA
Am Heart J 164:664-71. 2012....
- Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg
Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 165:622-9. 2013..All patients with atrial fibrillation (AF) require optimization of their ventricular rate. Factors leading to use of additional rhythm control in clinical practice have not been thoroughly defined...
- Treatment pathways and quality improvement for patients with acute myocardial infarction at a tertiary care centerBenjamin A Steinberg
Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27705, USA
Crit Pathw Cardiol 11:77-80. 2012..There is also a structured process for review of cases and quality improvement, which incorporates physicians, administrators, and emergency medical personnel...
- Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillationBenjamin A Steinberg
Duke University Medical Center, Durham, NC
J Am Heart Assoc 2:e000535. 2013..Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis in atrial fibrillation. Adoption patterns of this new agent in community practice are unknown...
- Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg
MPH, Duke University Medical Center and Duke Clinical Research Institute, 2400 Pratt St, Ste 7009, Durham, NC 27705, USA
Circulation 128:721-8. 2013..We assessed concomitant ASA use and its association with clinical outcomes among AF patients treated with OAC...
- Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation RegistryBenjamin A Steinberg
Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Clinical Research Institute, Durham, North Carolina
Clin Cardiol 37:7-13. 2014..Postoperative atrial fibrillation (POAF) is a well-recognized complication of cardiac surgery; however, its management remains a challenge, and the implementation and outcomes of various strategies in clinical practice remain unclear...
- Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgeryJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
Am J Cardiol 112:954-60. 2013..In this high-risk population, we were unable to demonstrate that any of the commonly used preventive agents were associated with lower rates of AF compared with alternatives or no treatment. ..
- Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomesBenjamin A Steinberg
Duke University Medical Center, Durham, NC, USA
Circulation 126:65-75. 2012..Heart failure with preserved ejection fraction (EF) is a common syndrome, but trends in treatments and outcomes are lacking...
- Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studiesBenjamin A Steinberg
Duke Center for Atrial Fibrillation, Electrophysiology Section, Duke University Medical Center, Durham, NC, USA
J Interv Card Electrophysiol 37:213-21. 2013..Dabigatran is approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). The safety and effectiveness of periprocedural dabigatran in ablation for AF are unknown...